|
显示项目 735196-735205 / 2348973 (共234898页)
<< < 73515 73516 73517 73518 73519 73520 73521 73522 73523 73524 > >>
每页显示[10|25|50]项目
| 臺大學術典藏 |
2021-01-19T12:08:53Z |
Risperidone exacerbates glucose intolerance, nonalcoholic fatty liver disease, and renal impairment in obese mice
|
Tsai, Hsiao Pei; Hou, Po Hsun; Mao, Frank Chiahung; Chang, Chia Chia; WEI-CHENG YANG; Wu, Ching Feng; Liao, Huei Jyuan; Lin, Tzu Chun; Chou, Lan Szu; Hsiao, Li Wei; Chang, Geng Ruei |
| 國立臺灣大學 |
2005 |
Risperidone for Pre-Existing Severe Tardive Dyskinesia: A 48-Week Prospective Follow-up Study
|
白雅美; 林知遠; 周碧瑟; 林朝誠; BAI, YA-MEI; LIN, CHIH-YUAN; CHOU, PESUS; LIN, CHAO-CHENG |
| 國立臺灣大學 |
2003 |
Risperidone for Severe Tardive Dyskinesia: A 12-Week Randomized, Double- Blind, Placebo-Controlled Study
|
白雅美; 林朝誠; BAI, YA-MEI; LIN, CHAO-CHENG |
| 國立臺灣大學 |
2001 |
Risperidone for Tardive Dyskinesia
|
白雅美; 平烈勇; 林朝誠; BAI, YA-MEI; PYNG, LEIN-YUNG; LIN, CHAO-CHENG |
| 淡江大學 |
2004-03 |
Risperidone response and 5-HT6 receptor gene variance : Genetic association analysis with adjustment for nongenetic confounders
|
Lane, Hsien-yuan; Lin, Cheng-chieh; Huang, Chiung-hsien; 張玉坤; Chang, Yue-cune; Hsu, Shih-kuan; Chang, Wen-ho |
| 中國醫藥大學 |
2004-03 |
Risperidone Response and 5-HT6 Receptor Gene Variance: Genetic Association Analysis with Adjustment for Nongenetic Confounders
|
藍先元(Hsien-Yuan Lane)*; 林正介(Cheng-Chieh Lin); 黃瓊賢(Chiung-Hsien Huang); 張玉坤(Yue-Cune Chang); 許世寬(Shih-Kuan Hsu); 張文和(Wen-Ho Chang) |
| 中國醫藥大學 |
2004 |
Risperidone response and 5-HT6 receptor gene variance: genetic association analysis with adjustment for nongenetic confounders
|
Lane, HY; Lin, CC; Huang, CH; Chang, YC; Hsu, SK; Chang, WH |
| 中國醫藥大學 |
2004 |
Risperidone response and 5-HT6 receptor gene variance: genetic association analysis with adjustment for nongenetic confounders
|
Lane, HY; Lin, CC; Huang, CH; Chang, YC; Hsu, SK; Chang, WH |
| 國立成功大學 |
2006 |
Risperidone 加上 Dextromethorphan 與 Risperidone 加上安慰劑之對照組比較治療精神分裂症之療效的隨機雙盲臨床試驗
|
陸汝斌 |
| 國立成功大學 |
2001-04-15 |
Risperidone, clozapine, haloperidol, sulpiride, and chlorpromazine attenuate longterm potentiation in the rat hippocampal CA1 region: A guide for choosing antipsychotic agents while treating noncognitive symptoms associated with Alzheimer's disease
|
Su, C. L.; Wu, S. F.; Gean, Po-Wu |
显示项目 735196-735205 / 2348973 (共234898页)
<< < 73515 73516 73517 73518 73519 73520 73521 73522 73523 73524 > >>
每页显示[10|25|50]项目
|
